Renaissance Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBRS
Cerebras Systems
CBRS
|
+$4.15M |
| 2 |
CRCL
Circle Internet Group
CRCL
|
+$3.76M |
| 3 |
Kodiak Gas Services
KGS
|
+$3.42M |
| 4 |
MDLN
Medline Inc
MDLN
|
+$3.16M |
| 5 |
CRWV
CoreWeave
CRWV
|
+$2.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$12.1M |
| 2 |
CAVA Group
CAVA
|
+$4.45M |
| 3 |
Arm
ARM
|
+$3.87M |
| 4 |
Astera Labs
ALAB
|
+$3.76M |
| 5 |
Atmus Filtration Technologies
ATMU
|
+$2.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.52% |
| 2 | Healthcare | 12.82% |
| 3 | Industrials | 12.68% |
| 4 | Consumer Discretionary | 9.49% |
| 5 | Communication Services | 6.52% |
No holdings matched the selected filter criteria.
Similar funds
Renaissance Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Renaissance Capital held 57 positions worth $181M, up 31% from $138M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Renaissance Capital deployed $16.4M of net new capital in Q2 2026, opening 10 new positions and adding to 36 existing holdings. Its largest new stake was Cerebras Systems: 17,642 shares worth $3.9M.
By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 40% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Arm, an estimated $3.87M trimmed.
- Renaissance Capital's largest Q2 2026 buy was Cerebras Systems: 17,642 shares worth $3.9M.
- Renaissance Capital added most to Circle Internet Group in Q2 2026, an estimated $3.76M increase.
- Renaissance Capital's biggest Q2 2026 reduction was Arm, cutting an estimated $3.87M.
- Renaissance Capital fully exited Kenvue in Q2 2026, selling an estimated $12.1M.
- Renaissance Capital's ten largest holdings make up 60% of its $181M portfolio in Q2 2026.
- Renaissance Capital opened 10 new positions and closed 5 in Q2 2026.
- Renaissance Capital's portfolio value rose 31% quarter-over-quarter to $181M.
Based on Renaissance Capital's 13F filing for Q2 2026, filed 5 Aug 2026.